Incentives for Global Public Health: Patent Law and Access to Essential Medicines
Cambridge: Cambridge University Press, 2010
Posted: 9 Jul 2009 Last revised: 16 May 2018
Date Written: 2010
Abstract
Introduction
Access to Essential Medicines: Public Health and International Law
Professor Thomas Pogge, Dr Matthew Rimmer, and Professor Kim Rubenstein Part I International Trade 1. TRIPS and Essential Medicines: Must One Size Fit All? Making the WTO Responsive to the Global Health Crisis
Professor Rochelle Cooper Dreyfuss, New York University 2. The TRIPS Waiver as a Recognition of Public Health Concerns in the WTO
Associate Professor Andrew Mitchell and Associate Professor Tania Voon, University of Melbourne 3. Public Law Challenges to the Regulation of Pharmaceutical Patents in the US Bilateral Free Trade Agreements
Dr Hitoshi Nasu, The Australian National University 4. Global Health and Development: Patents and Public Interest
Associate Professor Elizabeth Siew Kuan Ng, National University of Singapore
Part II Innovation 5. The Health Impact Fund: Boosting Innovation without Obstructing Free Access
Professor Thomas Pogge, Yale University and The Australian National University 6. The Health Impact Fund: A Critique
Dr Kathleen Liddell, University of Cambridge 7. A Prize System as a Partial Solution to the Health Crisis in the Developing World
Professor William W. Fisher and Talha Syed, Harvard Law School 8. Innovation and Insufficient Evidence: The Case for a WTO-WHO Agreement on Health Technology Safety and Cost-Effectiveness Evaluation
Associate Professor Thomas Faunce, The Australian National University Part III Intellectual Property 9. Opening the Dam: Patent Pools, Innovation, and Access to Essential Medicines
Professor Dianne Nicol and Dr Jane Nielsen, University of Tasmania 10. Open Source Drug Discovery: A Revolutionary Paradigm or a Utopian Model?
Dr Krishna Ravi Srinivas, Research Information System for Developing Countries (RIS), India 11. Accessing and Benefit Sharing Avian Influenza Viruses through the World Health Organisation: a CBD and TRIPS Compromise thanks to Indonesia’s Sovereignty Claim?
Dr Charles Lawson, Griffith University Faculty of Law and Associate Professor Barbara Hocking, Queensland University of Technology 12. The Lazarus Effect: The (RED) Campaign and Creative Capitalism
Dr Matthew Rimmer, The Australian National University Part IV Health-Care 13. Beyond TRIPS: The Role of Non-state Actors and Access to Essential Medicines
Professor Noah Benjamin Novogrodsky, University of Toronto 14. Securing Health Through Rights
Katharine Young, Harvard University
15. The Role of National laws in Reconciling Constitutional Right to Health with TRIPS Obligations: An Examination of the Glivec Patent Case in India
Dr Rajshree Chandra, Delhi University 16. Tipping Point: Thai Compulsory Licenses Redefine Essential Medicines Debate
Jonathan Burton-MacLeod, The Australian National University
Bibliography
Keywords: Access to Essential Medicines, International Trade Law, Innovation, Intellectual Property, Health-care, Public Law, International Law
Suggested Citation: Suggested Citation